MaxCyte, Inc. Common Stock (NASDAQ: MXCT) last traded at $1.38, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from MaxCyte, Inc. Common Stock’s own filings and are restated only when a new one is published.
MaxCyte, Inc. Common Stock trades on NASDAQ under the ticker MXCT. Its market capitalisation is $142.42 million.
Valuation measures for MaxCyte, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $142.42M |
|---|---|
| Enterprise value | $153.30M |
| Price / sales | 4.59 |
| Price / book | 0.90 |
| Beta | 1.73 |
Trailing-twelve-month figures tagged in MaxCyte, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $31.05M |
|---|---|
| Net income (TTM) | -$35.64M |
| EPS (TTM) | -$0.320 |
| Gross margin | 79.23% |
| Operating margin | -134.59% |
| Return on equity | -22.45% |
| Cash | $15.04M |
Range and volume for MXCT over the past 52 weeks.
| 52-week high | $1.87 |
|---|---|
| 52-week low | $0.643 |
| Volume | 435.8K |
| Average volume | 1.18M |
| Previous close | $1.38 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.